Michael Platten, MD
Neurologist, Chair of Neurology
Brain Tumor Immunotherapy
@dkfz.bsky.social
@platten-lab.bsky.social
@uniheidelberg.bsky.social
Medical Faculty Mannheim
Founder Tcelltech
President @eanoassociation.bsky.social
Ambassador for the @erc.europa.eu
- Reposted by Michael Platten, MDCan immunotherapy ever work in #glioblastoma? In a new #NatureCancer review, we share our perspective on current limitations and future directions: www.nature.com/articles/s43... #NORLUX, #LIH , @fnr.lu #TELEVIE, @glioresolve.bsky.social, @michael-platten.bsky.social
- Reposted by Michael Platten, MD👉 We are excited to announce that the #EANO2025 Abstract Book is now available online! Download & explore it today: lnkd.in/dg79p6wM #AbstractBook #NeuroOncology #neurosurgery #cancernurse #neuropathology #radiotherapy #AHP #btsm
- Reposted by Michael Platten, MDThe October issue of #ScienceImmunology is out! This month's cover highlights a Review that delves into brain tumor development and examines factors contributing to the immunosuppressive brain tumor microenvironment. Learn about this and more: scim.ag/46HgHcl
- The immunology of brain tumors | Science Immunology www.science.org/doi/10.1126/... Happy to share this review article by @lukasbunse.bsky.social, Theresa Bunse and I @platten-lab.bsky.social, Michael Kilian, Fran Quintana @quintanalabhms.bsky.social.
- Reposted by Michael Platten, MD🧠 Recently published in Neuro-Oncology: EANS–EANO Guidelines on the Extent of Resection in Gliomas. We’re proud to share the outcome of collaborative effort by the joint task force of EANS and EANO, providing evidence-based recommendations for clinical practice. 🔗 academic.oup.com/neuro-oncolo...
- Reposted by Michael Platten, MD💡Only a few seats left for the EANO Tumor Board 2025, taking place on October 15 in Prague. Join us for interactive case-based discussions and expert insights. Registration is free for EANO members. Please register by October 3. Learn more: www.eano.eu/eanomeetings...
- Reposted by Michael Platten, MDDiscover Neuro-Oncology Pediatrics, a new #OA journal launched by @eanoassociation.bsky.social & @neuroonc.bsky.social with editorial leadership from EANO, SNO, & ASNO, focused on advancing care for children and young adults with CNS tumors. See the first articles: oxford.ly/4mNN1iF
- Reposted by Michael Platten, MD📣 New journal launch! Neuro-Oncology Pediatrics is live — an open-access journal advancing global research and care for children & young adults with brain tumors. A joint EANO & @neuroonc.bsky.social initiative. 🔗 Read more: www.eano.eu/about/news/n... #NeuroOncology @oxfordacademic.bsky.social
- Excited to announce that we have completed accrual of the INTERCEPT-H3 trial (NCT04808245). This phase 1 first-in-human trial explores safety and immunogenicity of a long peptide vaccine targeting the clonal driver mutation H3K27M in adult patients with newly diagnosed diffuse midline gliomas 1/
- combined with radiotherapy and the immune checkpoint inhibitor atezolizumab. The trial was based on encouraging results in patients with recurrent diffuse midline gliomas www.nature.com/articles/s41... We will now follow-up our patiens, analyze the data and continue our analyses 2/
- in this "reverse translation" trial which was supported by the German Cancer Aid. Huge thanks to @dkfz.bsky.social as the trial sponsor, the fantastic NCT Trial Center, all participating sites from the Neurooncology Working Group @krebsgesellschaft.bsky.social 3/
-
View full threadan incredibly dedicated team of clinical trialists, basic and translational researchers and immune monitoring team @dkfz.bsky.social, @dkfz-iic.bsky.social, I have the privilege to work with with the goal to develop a viable tratment for patients with this devastating disease. 5/5
- Reposted by Michael Platten, MD📣 Have you heard? Registration for #EANO2025, taking place Oct 16-19, 2025 in #Prague (CZ) is open! Don’t miss out on this fantastic experience to meet experts in the field of #NeuroOncology. Early Bird fees available until July 31, 2025. 👉 eano.eu/eano2025/reg... #braincancer #medsky
- Reposted by Michael Platten, MD🧠 June 8 is #WorldBrainTumorDay — raising awareness & understanding of brain tumors. EANO supports progress in #NeuroOncology through research, education & collaboration. 🔗 Learn more: www.eano.eu #btsm #BrainTumor #Oncology
- Reposted by Michael Platten, MDWissenschaft braucht verlässliche Infrastrukturen - viele davon liegen noch in den USA. Der WR-Vorsitzende @wickwolfgang.bsky.social fordert in der @faznet.bsky.social eine europäische Strategie für mehr Unabhängigkeit👉 www.faz.net/aktuell/wiss... #DigitaleSouveränität #Forschung #Infrastruktur
- Reposted by Michael Platten, MDJoin us this week on Thursday (22nd May) for our next i2 seminar! This week it’s all about T cells in cancer!
- Reposted by Michael Platten, MDThe organizing committee of the UNITE conference would like to thank all speakers for their excellent presentations and all participants for the valuable discussions. @wickwolfgang.bsky.social @michael-platten.bsky.social
- Reposted by Michael Platten, MD🧠 Join the next #EANOYoungsters Journal Club on June 5, 16:30–17:30 CEST! Discussing: "Rapid molecular profiling of CNS tumors" www.nature.com/articles/s41... (Patel et al., Nat Med 2025) 📍Free & open to all EANO members 🔗 www.eano.eu #NeuroOncology #BrainTumors #JournalClub
- Reposted by Michael Platten, MDThe second day of the UNITE conference. Today there will also be a contribution from a patient on the book “Alles gut? Alles gut.” by Marlene Assmann. www.jacobystuart.de/buecher-von-...
- Reposted by Michael Platten, MDThe SynthImmune project by Heidelberg University& partner institutes advances a "bottom-up" synthetic biology approach to immunotherapies. Hoping they do well in the German government's Excellence Strategy—anticipating the announcement on 22 May. Perspective article: www.nature.com/articles/s41...
- Reposted by Michael Platten, MD⏱️ Clock is ticking! Final call for abstract submissions for #EANO2025 in #Prague. Don't miss this chance to share your work contribute to the advancement of #NeuroOncology. Submit now via our official event website: www.eano.eu/eano2025/ until May 6, 2025, 23.59 CEST! @oncoalert.bsky.social
- Reposted by Michael Platten, MDWir freuen uns, die UNITE-Glioblastom-Konferenz ankündigen zu können, die am 14. und 15. Mai 2025 im DKFZ-Kommunikationszentrum in Heidelberg stattfinden wird. melden Sie sich heute an: www.unite-glioblastoma.de/unite-confer...
- Reposted by Michael Platten, MD🚀 We are proud to launch the new "Ambassadors for the ERC" initiative, together with @ercgrantees.bsky.social ! We aim to empower researchers across Europe to advocate for frontier research. Find out more 👉 bit.ly/44bQzp7 🌟 Excited to see what can be achieved! #Amb4ERC
- Reposted by Michael Platten, MD@michael-platten.bsky.social has been selected and nominated as Ambassador for the ERC network. The @erc.europa.eu & the @ercgrantees.bsky.social launched the new Ambassadors on 28 April. This joint initiative aims to promote investment in frontier research and highlight the importance of #research.
- Reposted by Michael Platten, MD🗓️ Only one week to go! The abstract submission deadline for #EANO2025 in #Prague is approaching fast. This is your opportunity to share your findings, collaborate with peers, and be recognized in the field of #NeuroOncology. Submit your abstract now: www.eano.eu/eano2025/ #btsm
- Reposted by Michael Platten, MDDo you want to do your #postdoc in #cancerresearch with the most prestigious #fellowship in Europe? Apply to DKFZ Marie Skłodowska Curie MasterClasses by May 19. Projects in #cellandmolecularbiology #genomics #bioinformatics #immunology #medicaltechnology, #epidemiology. Apply here: t1p.de/nx6tu
- Reposted by Michael Platten, MD🚀 New publication! We developed a PTPRZ1-specific TCR-T cell therapy for glioblastoma. 🔬 Key findings: ✅ Identified a PTPRZ1-reactive TCR from a vaccinated patient ✅ Kills glioblastoma cells with no off-target effects ✅ Eliminates tumors in murine brain models 🔗 www.nature.com/articles/s41...
- Reposted by Michael Platten, MDDon’t miss our i2 seminar today at 4 pm where we will hear more about immunogenic cancer editopes and the lineage tree of tissue macrophage development. Join us for a lively discussion and snacks and drinks! 🧪 Today at 4pm in the main building 👇
- The i2 seminars are back on Thursday, April 17, at 4 pm with two talks by Dr. Bea Casati, Postdoc in the Papavasiliou Lab, and Larissa Frank, PhD student in the Rodewald Lab. Save the date and join us for a lively discussion! @dkfz.bsky.social @beacasati.bsky.social @larissafrank.bsky.social
- Reposted by Michael Platten, MDDon't forget to register - only one week left!
- 🕛 You have until the 23rd of April to register for #INCI25. After that, you will miss the latest #cancerbiology and #immunotherapy research developments. Claim your spot & see you in beautiful Bruges while there’s still time: vibbio.tech/4ic2SEZ #CancerBiology #Immunology #immunotherapy
- Reposted by Michael Platten, MD🚀 Just 2 weeks left to submit your abstract for #EANO2025 in #Prague! Don't miss your chance to share your research with the world. Submit your work by April 30 and join us for an incredible event this October. We can't wait to see your contributions! 🔬 eano.eu/eano2025/
- Huge congrats @lukasbunse.bsky.social, so well deserved, fantastic achievement. @hlsalliance.bsky.social @cn-hd.bsky.social @neurooncologyhd.bsky.social @mctneuroscience.bsky.social @platten-lab.bsky.social
- Herzlichen Glückwunsch: 🏆️ Juniorprofessor Dr. Peter Andre @peterandre.bsky.social , #Wirtschaftspolitik, @safefrankfurt.bsky.social @goetheuni.bsky.social 🏆️ Dr. Lukas Bunse @lukasbunse.bsky.social, #Neurologie, Universitätsmedizin Mannheim, Universität Mannheim 2/6
- Reposted by Michael Platten, MD🌍 #EANO2024 in Glasgow gathered 1,200+ global participants, featuring cutting-edge research and insights to shape the future of #NeuroOncology. Be part of this community at #EANO2025! Watch our highlight video & renew your membership today for many benefits! bit.ly/4i6djdF See you in Prague! 👋
- Reposted by Michael Platten, MD🚀From Glasgow to Prague: Shaping the Future Together! #EANO2024 in Glasgow was a huge success with unforgettable moments & inspiring talks! Watch the highlights bit.ly/3WL1oKg and get excited for #EANO2025 in Prague! What are you most excited about? #NeuroOncology
- Reposted by Michael Platten, MD📅 Mark your calendars! Abstract submissions for #EANO2025 are due April 30. Don’t miss your chance to showcase your #NeuroOncology research this October! 🌍✨ 🔬 Submit now: www.eano.eu/eano2025/abs... #btsm #neurosurgery #glioma #RadOnc #BrainCancer #cancernurse #AHP
- Reposted by Michael Platten, MD📣 Still time to register! Join the 3rd Annual Highlights of EANO/SNO 2024 webinar and hear key insights from #EANO2024 (Glasgow) and #SNO2024 (Boston). 🗓 March 7, 2025 | ⏰ 6:30 PM CET | 12:30 PM ET 🔗 Register now: eano.eu/eanowebinar/ @neuroonc.bsky.social
- Reposted by Michael Platten, MD🚀Abstract submission for #EANO2025 is open! Share your #NeuroOncology research at the 20th #EANO Meeting in Prague, Oct 16-19, 2025. We can't wait to see your contributions! 🗓️ Deadline: April 30, 2025, 23:59 CEST. 🔗 Details: www.eano.eu/eano2025/abs... #btsm #braintumor
- Reposted by Michael Platten, MD⏰ Still 2 weeks: Don’t miss the 3rd EANO-SNO Webinar! Our experts will discuss the top abstracts from #EANO2024 (Glasgow) & #SNO2024 (Houston), bringing you the latest updates in #NeuroOncology. 🗓️ March 7, 2025 ⏱️ 6:30-7:30pm CET Register today: eano.eu/eanowebinar/ @neuroonc.bsky.social
- Reposted by Michael Platten, MD📢 Don’t miss the Highlights of EANO/SNO 2024 Webinar! Join our experts as they discuss key abstracts from #EANO2024 (Glasgow) & #SNO2024 (Houston), covering the latest in #NeuroOncology. 🗓️ March 7, 2025 ⏱️ 6:30-7.30pm CET Register now: eano.eu/eanowebinar/ @neuroonc.bsky.social
- Reposted by Michael Platten, MDTumor-reactive T cell receptors are rapidly identified from lymphocyte scRNA-seq data go.nature.com/49O5INm rdcu.be/d8L1u
- Our very own outstanding MD student Kuralay Aman @platten-lab.bsky.social @dkfz.bsky.social received the @daadworldwide.bsky.social Award for International Students at Heidelberg University not only for her fantastic work on brain tumor immunotherapy but also for her societal engagement. Brava!
- Reposted by Michael Platten, MDHeidelberg is placing first when it comes to #startup founders per capita in #Germany. With 13.5 new startups per 100.000 inhabitants in 2024, Heidelberg is outperforming startup hotspots such as #Berlin and #Munich. The full report is here: startupverband.de/fileadmin/st...
- Reposted by Michael Platten, MD🚨 Still 3 days: #EANO Seminars 2026 – Call for Applications! 📅 Deadline: Jan 8, 2025 📍 Location: University/hospital campus preferred Learn more 👉eano.eu Let’s bring #EANOSeminars to your region! #NeuroOncology #btsm
- Reposted by Michael Platten, MD🎉We wish you a Happy New Year! Join us for our virtual Cancer Neuroscience Heidelberg Seminars: below is the 2025 winter program. Cancer Neuroscience is funded by the European Center for Neurooncology (EZN) - Dietmar Hopp Stiftung us06web.zoom.us/meeting/regi... us06web.zoom.us/meeting/regi...
- Reposted by Michael Platten, MDWe have an open professorship in #synbio / biological engineering in Heidelberg! jobs.zeit.de/jobs/full-pr... Check it out!
- Reposted by Michael Platten, MD📢 Reminder: EANO Seminars 2026 – Call for Applications! Don't miss the chance to host this educational event on #CNSOncology! 📅 Deadline: Jan 8, 2025 📍 Location: University/hospital campus preferred Learn more at eano.eu Let’s bring #EANOSeminars to your region!
- Great fun to write this perspective with @lukasbunse.bsky.social @platten-lab.bsky.social @dkfz-iic.bsky.social @dkfz.bsky.social on a highly interesting study by the Bardeesy Lab. This study provides additional mechanistic rationale to combine IDH inhibitors with T cell activating therapies.
- A recent study unpicks a key immune-mediated mechanism of mutant IDH–blocking drugs such as vorasidenib in the treatment of IDH-mutant glioma. Learn more in a new Clinical Implications of Basic Research article: nej.md/4f3dIMf #MedSky
- It's a wrap for Dr. Dennis Agardy @platten-lab.bsky.social - outstanding PhD thesis defense - well deserved celebration - so glad he'll stay for a postdoc for two more years.
- Could not be any prouder. Stellar work, fantastic lecture - day to remember. Welcome to the faculty @lukasbunse.bsky.social.
- Today we congratulate @lukasbunse.bsky.social for his successful dissertation and his inaugural lecture at umm Mannheim. Congratulations!!
- Fantastic Grand Round by Francisco Quintana @harvardmed.bsky.social here at the Medical Facultx Mannheim, Heidelberg University. Great discussions, many new ideas exchanged on CNS immunity. @researchlifesci.bsky.social @neurooncologyhd.bsky.social
- Towards controlling solid cancers woth CAR T cells. Highly relevant work substantiating the role of IL-15. rdcu.be/d1GHH
- More evidence pointing to immune evasion as an early feature of IDH-mutant gliomas - suppression of IFN-signalling as a common trait in low and high grade disease. Fantastic work by the Bernstein Lab. rdcu.be/d1E6p
- The #FallingWalls Science Summit on the occasion of the 35th anniversary of the Fall of the Berlin Wall made a lasting impression. Honored to be among the awardees and to close the event (8:14.30) by showcasing our work @platten-lab.bsky.social youtube.com/live/FX6H36e...
- Reposted by Michael Platten, MDI am moving here in the hope to restart science twitter in the blue sky! I look forward to exciting posts, pictures and discussions.
- It was great fun to contribute to this review - a guide towards more effective, affordable, and robust immunotherapies - grateful for the energy and creativity of @kgoepfrich.bsky.social and this new research field taking off @researchlifesci.bsky.social.
- What happens when you apply design principles from bottom-up synthetic biology to immunology? In Heidelberg and together with @FrischknechtLab @platten_michael & Oliver Fackler we compiled the prospects of bottom-up synthetic immunology @NatureNano rdcu.be/dR0r0
- Reposted by Michael Platten, MDThat’s a wrap on #SNO2024 in Houston! ✨ The #EANO team had an amazing time sharing knowledge, meeting outstanding colleagues and friends, and being part of such an inspiring event. Thank you, @neuroonc.bsky.social, for hosting this great conference! #neurooncology #braintumor #cancer #btsm
- Reposted by Michael Platten, MD📣 Just Released: The #EANO Guideline on molecular testing of #meningiomas for targeted therapy selection! Evidence-based guidance for patient care & clinical trials, and show of areas for which additional research is warranted. doi.org/10.1093/neuo... #TargetedTherapy #ICOM @oncoalert.bsky.social
- Reposted by Michael Platten, MDLooking forward to presenting the NOA-20/N2M2 trial today @SNO2024. Tx to @michael-platten.bsky.social @NOA & colleagues!
- Reposted by Michael Platten, MDExciting news! The #EANO Research Grant is here to drive forward innovative and collaborative research in #NeuroOncology, supporting advancements in cancer care and science. 🧠✨ Applications open until January 23, 2025! Learn more: bit.ly/4ggCAkH #btsm #CancerResearch
